JP Stock MarketDetailed Quotes

4565 Nxera Pharma

Watchlist
  • 1491
  • +3+0.20%
20min DelayMarket Closed Aug 9 15:00 JST
134.05BMarket Cap-17102P/E (Static)

Nxera Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
574.06%8.11B
388.97%4.61B
-18.00%12.77B
5.25%7.29B
-46.18%3.33B
-10.09%1.2B
-15.73%943M
-12.10%15.57B
-50.94%6.93B
1,224.20%6.18B
Cost of revenue
1,630.08%2.3B
1,194.57%1.19B
234.99%3.1B
840.86%1.75B
439.23%1.13B
-45.27%133M
-68.06%92M
-0.75%926M
-36.95%186M
9.42%209M
Gross profit
442.80%5.81B
301.88%3.42B
-34.00%9.66B
-17.80%5.54B
-63.16%2.2B
-2.28%1.07B
2.41%851M
-12.73%14.64B
-51.24%6.74B
2,064.86%5.98B
Operating expense
95.05%6.39B
130.76%6.5B
71.23%19.19B
162.95%7.08B
116.26%6.03B
21.57%3.27B
-7.31%2.82B
-13.82%11.21B
-53.82%2.69B
5.05%2.79B
Selling and administrative expenses
199.04%4.37B
229.13%3.65B
127.67%9.97B
227.51%3.95B
280.22%3.44B
60.48%1.46B
-18.09%1.11B
11.09%4.38B
14.73%1.21B
-5.14%905M
-General and administrative expense
199.04%4.37B
229.13%3.65B
127.67%9.97B
227.51%3.95B
280.22%3.44B
60.48%1.46B
-18.09%1.11B
11.09%4.38B
14.73%1.21B
-5.14%905M
Research and development costs
11.62%2.32B
61.62%3.16B
35.16%10.08B
67.23%3.06B
54.49%2.97B
9.93%2.08B
8.48%1.96B
25.68%7.45B
14.51%1.83B
11.01%1.93B
Other operating expenses
-96.67%1M
--2M
4,600.00%94M
6,000.00%61M
--2M
500.00%30M
----
-99.94%2M
-99.97%1M
----
Total other operating income
3.67%311M
27.09%319M
50.80%944M
--0
790.91%392M
156.41%300M
107.44%251M
7,725.00%626M
416.36%348M
18.92%44M
Operating profit
73.77%-578M
-56.62%-3.08B
-377.24%-9.53B
-137.87%-1.53B
-219.91%-3.82B
-37.92%-2.2B
10.97%-1.96B
-8.98%3.44B
-49.36%4.05B
234.22%3.19B
Net non-operating interest income (expenses)
-29.64%216M
177.23%280M
-1,140.86%-1.15B
-531.03%-1.28B
-330.33%-281M
420.34%307M
242.25%101M
97.42%-93M
93.94%-203M
156.22%122M
Non-operating interest income
-17.50%415M
70.33%465M
102.26%1.34B
1,146.43%349M
25.86%365M
117.75%503M
131.36%273M
233.17%663M
110.04%28M
-4.92%290M
Non-operating interest expense
1.53%199M
7.56%185M
230.03%2.5B
605.63%1.63B
284.52%646M
13.95%196M
-8.99%172M
-80.09%756M
-92.48%231M
-67.82%168M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
0
-958.00%-429M
612.12%338M
-81.33%-301M
Special income (charges)
0
-991.26%-1.84B
0
-1.84B
Less:Write off
----
----
--0
----
----
----
----
991.26%1.84B
--0
--1.84B
Other non-operating income (expenses)
Income before tax
80.92%-362M
-50.08%-2.8B
-1,090.72%-10.68B
-167.25%-2.82B
-449.66%-4.11B
-6.27%-1.9B
25.39%-1.86B
148.96%1.08B
-8.70%4.19B
142.55%1.17B
Income tax
185.55%1.06B
205.21%485M
-601.01%-3.49B
-550.26%-2.61B
-4.76%820M
-290.85%-1.24B
-7.96%-461M
219.18%696M
-66.78%579M
126.65%861M
Net income
-116.11%-1.42B
-134.02%-3.28B
-1,982.98%-7.19B
-105.77%-208M
-1,673.48%-4.93B
55.18%-658M
32.27%-1.4B
-62.44%382M
26.92%3.61B
-33.69%313M
Net income continuous operations
-116.11%-1.42B
-134.02%-3.28B
-1,982.98%-7.19B
-105.77%-208M
-1,673.48%-4.93B
55.18%-658M
32.27%-1.4B
-62.44%382M
26.92%3.61B
-33.69%313M
Noncontrolling interests
Net income attributable to the company
-116.11%-1.42B
-134.02%-3.28B
-1,982.98%-7.19B
-105.77%-208M
-1,673.48%-4.93B
55.18%-658M
32.27%-1.4B
-62.44%382M
26.92%3.61B
-33.69%313M
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
-116.11%-1.42B
-134.02%-3.28B
-1,982.98%-7.19B
-105.77%-208M
-1,673.48%-4.93B
55.18%-658M
32.27%-1.4B
-62.44%382M
26.92%3.61B
-33.69%313M
Gross dividend payment
Basic earnings per share
-97.51%-15.86
-114.38%-36.68
-1,962.82%-87.18
-104.83%-2.13
-1,665.71%-59.81
55.29%-8.03
32.61%-17.11
-62.65%4.68
26.01%44.14
-34.14%3.82
Diluted earnings per share
-97.51%-15.86
-114.38%-36.68
-1,982.94%-87.18
-104.83%-2.13
-1,682.28%-59.81
55.29%-8.03
32.61%-17.11
-62.66%4.63
26.33%44.09
-34.26%3.78
Dividend per share
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 574.06%8.11B388.97%4.61B-18.00%12.77B5.25%7.29B-46.18%3.33B-10.09%1.2B-15.73%943M-12.10%15.57B-50.94%6.93B1,224.20%6.18B
Cost of revenue 1,630.08%2.3B1,194.57%1.19B234.99%3.1B840.86%1.75B439.23%1.13B-45.27%133M-68.06%92M-0.75%926M-36.95%186M9.42%209M
Gross profit 442.80%5.81B301.88%3.42B-34.00%9.66B-17.80%5.54B-63.16%2.2B-2.28%1.07B2.41%851M-12.73%14.64B-51.24%6.74B2,064.86%5.98B
Operating expense 95.05%6.39B130.76%6.5B71.23%19.19B162.95%7.08B116.26%6.03B21.57%3.27B-7.31%2.82B-13.82%11.21B-53.82%2.69B5.05%2.79B
Selling and administrative expenses 199.04%4.37B229.13%3.65B127.67%9.97B227.51%3.95B280.22%3.44B60.48%1.46B-18.09%1.11B11.09%4.38B14.73%1.21B-5.14%905M
-General and administrative expense 199.04%4.37B229.13%3.65B127.67%9.97B227.51%3.95B280.22%3.44B60.48%1.46B-18.09%1.11B11.09%4.38B14.73%1.21B-5.14%905M
Research and development costs 11.62%2.32B61.62%3.16B35.16%10.08B67.23%3.06B54.49%2.97B9.93%2.08B8.48%1.96B25.68%7.45B14.51%1.83B11.01%1.93B
Other operating expenses -96.67%1M--2M4,600.00%94M6,000.00%61M--2M500.00%30M-----99.94%2M-99.97%1M----
Total other operating income 3.67%311M27.09%319M50.80%944M--0790.91%392M156.41%300M107.44%251M7,725.00%626M416.36%348M18.92%44M
Operating profit 73.77%-578M-56.62%-3.08B-377.24%-9.53B-137.87%-1.53B-219.91%-3.82B-37.92%-2.2B10.97%-1.96B-8.98%3.44B-49.36%4.05B234.22%3.19B
Net non-operating interest income (expenses) -29.64%216M177.23%280M-1,140.86%-1.15B-531.03%-1.28B-330.33%-281M420.34%307M242.25%101M97.42%-93M93.94%-203M156.22%122M
Non-operating interest income -17.50%415M70.33%465M102.26%1.34B1,146.43%349M25.86%365M117.75%503M131.36%273M233.17%663M110.04%28M-4.92%290M
Non-operating interest expense 1.53%199M7.56%185M230.03%2.5B605.63%1.63B284.52%646M13.95%196M-8.99%172M-80.09%756M-92.48%231M-67.82%168M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests 0-958.00%-429M612.12%338M-81.33%-301M
Special income (charges) 0-991.26%-1.84B0-1.84B
Less:Write off ----------0----------------991.26%1.84B--0--1.84B
Other non-operating income (expenses)
Income before tax 80.92%-362M-50.08%-2.8B-1,090.72%-10.68B-167.25%-2.82B-449.66%-4.11B-6.27%-1.9B25.39%-1.86B148.96%1.08B-8.70%4.19B142.55%1.17B
Income tax 185.55%1.06B205.21%485M-601.01%-3.49B-550.26%-2.61B-4.76%820M-290.85%-1.24B-7.96%-461M219.18%696M-66.78%579M126.65%861M
Net income -116.11%-1.42B-134.02%-3.28B-1,982.98%-7.19B-105.77%-208M-1,673.48%-4.93B55.18%-658M32.27%-1.4B-62.44%382M26.92%3.61B-33.69%313M
Net income continuous operations -116.11%-1.42B-134.02%-3.28B-1,982.98%-7.19B-105.77%-208M-1,673.48%-4.93B55.18%-658M32.27%-1.4B-62.44%382M26.92%3.61B-33.69%313M
Noncontrolling interests
Net income attributable to the company -116.11%-1.42B-134.02%-3.28B-1,982.98%-7.19B-105.77%-208M-1,673.48%-4.93B55.18%-658M32.27%-1.4B-62.44%382M26.92%3.61B-33.69%313M
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders -116.11%-1.42B-134.02%-3.28B-1,982.98%-7.19B-105.77%-208M-1,673.48%-4.93B55.18%-658M32.27%-1.4B-62.44%382M26.92%3.61B-33.69%313M
Gross dividend payment
Basic earnings per share -97.51%-15.86-114.38%-36.68-1,962.82%-87.18-104.83%-2.13-1,665.71%-59.8155.29%-8.0332.61%-17.11-62.65%4.6826.01%44.14-34.14%3.82
Diluted earnings per share -97.51%-15.86-114.38%-36.68-1,982.94%-87.18-104.83%-2.13-1,682.28%-59.8155.29%-8.0332.61%-17.11-62.66%4.6326.33%44.09-34.26%3.78
Dividend per share
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
% Chg